Rheumatology News

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

Leaders who are willing to collaborate with both patients and other health care professionals are more likely to achieve optimal disease outcomes, according to experts who participated in a panel discussion.

Health care providers know of the broad potential AI offers for reducing burnout, but which products are actually available for use can be difficult to ascertain, especially considering electronic health record system compatibility.

Many people who experience side effects from cancer treatment wait nearly a month to see a specialist with the necessary expertise.

Specific interferon signatures may influence the symptoms and severity of systemic lupus erythematosus, with various interferon types potentially “contributing to distinct pathogenic processes,” according to recent findings.

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

Strictly controlling inflammation can heal bone erosions in rheumatoid arthritis, a process accompanied by changes in the Wnt signaling pathway, according to a presenter at the 2024 Association of Women in Rheumatology conference.

Holding others accountable and being held accountable for transgressions of all types can lead to growth in relationships, according to the keynote presenter at the 2024 Association of Women in Rheumatology annual conference.

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the launch of proposed biosimilar rituximab candidate Ituxredi, Dr. Reddy’s Laboratories announced in a press release.

Ongoing research into the disease processes of lupus has yielded an increased number of therapeutic targets, according to a presenter at the 2024 Association of Women in Rheumatology annual conference.